U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844070) titled 'A Study of Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy' on Sept. 21.
Brief Summary: This study aims to assess the real-world patterns of disease modifying therapy (DMT) use before, during, and after pregnancy in women with multiple sclerosis (MS). The study will use a pooled closed claims database containing closed payer medical and pharmacy claims data for patients in the United States (US).
Study Start Date: March 06
Study Type: OBSERVATIONAL
Condition:
Multiple Sclerosis
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Novartis Pharmaceuticals
Published by HT Digita...